In its upcoming report, Teva Pharmaceutical Industries Ltd. (TEVA) is predicted by Wall Street analysts to post quarterly earnings of $0.65 per share, reflecting an increase of 8.3% compared to the same period last year. Revenues are forecasted to be $4.08 billion, representing a year-over-year increase of 6%.Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 0.3% to its current level. This demonstrates the covering analysts' collective reassessment of their initia ...